Amsterdam – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has entered into an agreement to acquire SpectraWAVE, Inc., an innovator in Enhanced Vascular Imaging (EVI) of coronary arteries, angiography-based physiology assessments, and the use of AI in medical imaging. SpectraWAVE’s intravascular imaging and physiological assessment technologies provide advanced solutions…
AMSTERDAM: Philips, a global leader in health technology, announced its 2023 financial results, showing a 7% increase in comparable sales and a 10.5% increase in adjusted EBITA margin. The company also generated a free cash flow of EUR 1,582 million, up from EUR 1,018 million in 2022. The company attributed its strong performance to the…
AMSTERDAM: Philips’ third-quarter results show improved operational performance, with sales increasing 11% to EUR 4.5 billion and adjusted EBITA increasing to EUR 457 million, or 10.2% of sales. The company’s order book remains strong, and it has raised its outlook for the full year 2023 to 6-7% comparable sales growth and an adjusted EBITA margin…
AMSTERDAM: Royal Philips has completed the acquisition of BioTelemetry Inc., a leading U.S. based provider of remote cardiac diagnostics and monitoring. BioTelemetry’s financial results will be consolidated as part of Philips’ Connected Care business segment as of February 9, 2021. The acquisition of BioTelemetry is a strong fit with Philips’ cardiac care portfolio, and its…
Philips is catering to increasing demand for high-technology solutions that can help keep pollutants, bacteria and viruses at bay LAHORE: Royal Philips is stepping up its innovation efforts in air purification towards helping more people make the change to living healthier lives indoors. With a team of more than 100 scientists, doctors and engineers working…